Skip Navigation

Human Molecular Genetics 2005 14(Review Issue 2):R251-R258; doi:10.1093/hmg/ddi260
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kwiatkowski, D. J.
Right arrow Articles by Manning, B. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kwiatkowski, D. J.
Right arrow Articles by Manning, B. D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways

David J. Kwiatkowski1,* and Brendan D. Manning2

1Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, One Blackfan Circle, 6th Floor, Room 216, Boston, MA 02115, USA and 2Department of Genetics and Complex Diseases, Harvard School of Public Health, Boston, MA, USA

* To whom correspondence should be addressed. Tel: +1 6173559005; Fax: +1 6173559016; Email: dk{at}rics.bwh.harvard.edu

Received June 15, 2005; Accepted June 29, 2005

Tuberous sclerosis complex (TSC) is an autosomal dominant disorder that is characterized by benign tumors (hamartomas and hamartias) involving multiple organ systems, due to inactivating mutations in TSC1 or TSC2. Here, we review recent advances in our understanding of the growth and signaling functions of the TSC1 and TSC2 proteins. Led by seminal studies in Drosophila, the TSC1/TSC2 complex has been positioned in an ancestrally conserved signaling pathway that regulates cell growth. TSC1/TSC2 receives inputs from at least three major signaling pathways in the form of kinase-mediated phosphorylation events that regulate its function as a GTPase activating protein (GAP): the PI3K-Akt pathway, the ERK1/2-RSK1 pathway and the LKB1-AMPK pathway. TSC1/TSC2 functions as a GAP towards Rheb, which is a major regulator of the mammalian target of rapamycin (mTOR). In the absence of either TSC1 or TSC2, high levels of Rheb-GTP lead to constitutive activation of mTOR–raptor signaling, thereby leading to enhanced and deregulated protein synthesis and cell growth. As a specific inhibitor of mTOR, rapamycin has therapeutic potential for the treatment of TSC hamartomas.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cancer Res.Home page
J. D. Short, K. D. Houston, R. Dere, S.-L. Cai, J. Kim, C. L. Johnson, R. R. Broaddus, J. Shen, S. Miyamoto, F. Tamanoi, et al.
AMP-Activated Protein Kinase Signaling Results in Cytoplasmic Sequestration of p27
Cancer Res., August 15, 2008; 68(16): 6496 - 6506.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
W. Jiang, Z. Zhu, and H. J. Thompson
Dietary Energy Restriction Modulates the Activity of AMP-Activated Protein Kinase, Akt, and Mammalian Target of Rapamycin in Mammary Carcinomas, Mammary Gland, and Liver
Cancer Res., July 1, 2008; 68(13): 5492 - 5499.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
L. S. Pymar, F. M. Platt, J. M. Askham, E. E. Morrison, and M. A. Knowles
Bladder tumour-derived somatic TSC1 missense mutations cause loss of function via distinct mechanisms
Hum. Mol. Genet., July 1, 2008; 17(13): 2006 - 2017.
[Abstract] [Full Text] [PDF]

Home page
 J ANIM SCIHome page
T. A. Davis, A. Suryawan, R. A. Orellana, H. V. Nguyen, and M. L. Fiorotto
Postnatal ontogeny of skeletal muscle protein synthesis in pigs
J Anim Sci, April 1, 2008; 86(14_suppl): E13 - E18.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Li, F. Takeuchi, J.-a. Wang, Q. Fan, T. Komurasaki, E. M. Billings, G. Pacheco-Rodriguez, J. Moss, and T. N. Darling
Mesenchymal-epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomas
PNAS, March 4, 2008; 105(9): 3539 - 3544.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. R. Kimball, A. N. D. Do, L. Kutzler, D. R. Cavener, and L. S. Jefferson
Rapid Turnover of the mTOR Complex 1 (mTORC1) Repressor REDD1 and Activation of mTORC1 Signaling following Inhibition of Protein Synthesis
J. Biol. Chem., February 8, 2008; 283(6): 3465 - 3475.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. Yeager, C. Brewer, K. Q. Cai, X.-X. Xu, and A. Di Cristofano
Mammalian Target of Rapamycin Is the Key Effector of Phosphatidylinositol-3-OH Initiated Proliferative Signals in the Thyroid Follicular Epithelium
Cancer Res., January 15, 2008; 68(2): 444 - 449.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. J. Ravitz, L. Chen, M. Lynch, and E. V. Schmidt
c-myc Repression of TSC2 Contributes to Control of Translation Initiation and Myc-Induced Transformation
Cancer Res., December 1, 2007; 67(23): 11209 - 11217.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. Suryawan, R. A. Orellana, H. V. Nguyen, A. S. Jeyapalan, J. R. Fleming, and T. A. Davis
Activation by insulin and amino acids of signaling components leading to translation initiation in skeletal muscle of neonatal pigs is developmentally regulated
Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1597 - E1605.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J.-L. Liu, Z. Mao, T. A. LaFortune, M. M. Alonso, G. E. Gallick, J. Fueyo, and W.K. A. Yung
Cell Cycle Dependent Nuclear Export of Phosphatase and Tensin Homologue Tumor Suppressor Is Regulated by the Phosphoinositide-3-Kinase Signaling Cascade
Cancer Res., November 15, 2007; 67(22): 11054 - 11063.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
O. M. Tsygankova, G. V. Prendergast, K. Puttaswamy, Y. Wang, M. D. Feldman, H. Wang, M. S. Brose, and J. L. Meinkoth
Downregulation of Rap1GAP Contributes to Ras Transformation
Mol. Cell. Biol., October 1, 2007; 27(19): 6647 - 6658.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
Y. Gui, G. H. He, M. P. Walsh, and X.-L. Zheng
Predisposition to tetraploidy in pulmonary vascular smooth muscle cells derived from the Eker rats
Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L702 - L711.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
L. Meikle, D. M. Talos, H. Onda, K. Pollizzi, A. Rotenberg, M. Sahin, F. E. Jensen, and D. J. Kwiatkowski
A Mouse Model of Tuberous Sclerosis: Neuronal Loss of Tsc1 Causes Dysplastic and Ectopic Neurons, Reduced Myelination, Seizure Activity, and Limited Survival
J. Neurosci., May 23, 2007; 27(21): 5546 - 5558.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
M. Arad, C. E. Seidman, and J.G. Seidman
AMP-Activated Protein Kinase in the Heart: Role During Health and Disease
Circ. Res., March 2, 2007; 100(4): 474 - 488.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
D. Massey-Harroche, M.-H. Delgrossi, L. Lane-Guermonprez, J.-P. Arsanto, J.-P. Borg, M. Billaud, and A. Le Bivic
Evidence for a molecular link between the tuberous sclerosis complex and the Crumbs complex
Hum. Mol. Genet., March 1, 2007; 16(5): 529 - 536.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. Suryawan, J. Escobar, J. W. Frank, H. V. Nguyen, and T. A. Davis
Developmental regulation of the activation of signaling components leading to translation initiation in skeletal muscle of neonatal pigs
Am J Physiol Endocrinol Metab, October 1, 2006; 291(4): E849 - E859.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. W. Arvisais, A. Romanelli, X. Hou, and J. S. Davis
AKT-independent Phosphorylation of TSC2 and Activation of mTOR and Ribosomal Protein S6 Kinase Signaling by Prostaglandin F2{alpha}
J. Biol. Chem., September 15, 2006; 281(37): 26904 - 26913.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
A Munnich
Advances in genetics: what are the benefits for patients?
J. Med. Genet., July 1, 2006; 43(7): 555 - 556.
[Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.